These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17625963)

  • 1. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay.
    Fytili P; Tiemann C; Wang C; Schulz S; Schaffer S; Manns MP; Wedemeyer H
    J Clin Virol; 2007 Aug; 39(4):308-11. PubMed ID: 17625963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
    Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
    J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
    Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse.
    Gerotto M; Dal Pero F; Bortoletto G; Ferrari A; Pistis R; Sebastiani G; Fagiuoli S; Realdon S; Alberti A
    J Hepatol; 2006 Jan; 44(1):83-7. PubMed ID: 16271794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
    Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
    J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current and future applications of viral clearance kinetics in the treatment of hepatitis C].
    Buti M
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():24-9. PubMed ID: 15195531
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of a rapid negativity of serum virus C viremia during treatment with interferon alpha in patients with chronic hepatitis C].
    Moulin V; Harzic M; Doll J; Dubeaux B; Ghnassia JC; Andrieu J
    Pathol Biol (Paris); 1996 May; 44(5):468-72. PubMed ID: 8758497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M
    J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term evaluation of patients with sustained virologic remission by highly sensitive HCV RNA assays: no evidence for viral persistence.
    Schlosser B; Biermer M; Weich V; van Bömmel F; Berg T
    J Clin Virol; 2011 Jan; 50(1):88-9. PubMed ID: 20947416
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant.
    Hsiao HH; Liu YC; Wang HC; Wu CH; Cho SF; Hsu JF; Tsai HJ; Hsiao SY; Chang CS; Lin SF; Liu TC; Chuang WL; Yu ML
    Transpl Infect Dis; 2014 Dec; 16(6):1003-6. PubMed ID: 25367218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients.
    Donato MF; Bastiampillai AJ; Manini M; Monico S
    J Antimicrob Chemother; 2013 Apr; 68(4):974-5. PubMed ID: 23221629
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance evaluation of the Artus hepatitis C virus QS-RGQ assay.
    Paba P; Fabeni L; Perno CF; Ciotti M
    J Virol Methods; 2012 Jan; 179(1):77-80. PubMed ID: 22001273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.